Interact to see
Advertisement
Advertisement
FSPHX vs HGHRX
FSPHX vs HGHRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
FSPHX vs. HGHRX commentary
Sep 01, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSPHX is a StrongBuy and HGHRX is a Buy.
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 5.74B vs. HGHRX (751M). FSPHX pays higher dividends than HGHRX: FSPHX (0.02) vs HGHRX (0.00). FSPHX was incepted earlier than HGHRX: FSPHX (44 years) vs HGHRX (19 years). HGHRX (1.63) is less costly to investors than FSPHX (0.63). FSPHX (40.00) and HGHRX (40.00) have comparable annual turnover. FSPHX (0) and HGHRX (0) have matching initial minimum investment requirements. FSPHX annual gain was more profitable for investors over the last year : -15.59 vs. HGHRX (-21.02). FSPHX return over 5 years is better than : -14.61 vs. HGHRX (-20.77).
| FSPHX | HGHRX | FSPHX / HGHRX | |
| Total Expense Ratio | 0.63 | 1.63 | 39% |
| Annual Report Gross Expense Ratio | 0.63 | 1.63 | 39% |
| Fund Existence | 44 years | 19 years | - |
| Gain YTD | -2.385 | -3.866 | 62% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 5.74B | 751M | 764% |
| Annual Yield % from dividends | 0.02 | 0.00 | - |
| Returns for 1 year | -15.59 | -21.02 | 74% |
| Returns for 3 years | -0.47 | -0.79 | 60% |
| Returns for 5 years | -14.61 | -20.77 | 70% |
| Returns for 10 years | 22.39 | -13.75 | -163% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement